OLD Category: signatures

Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients

• Sugita BM et al.,

Reconstruction of the Global Neural Crest Gene Regulatory Network In Vivo

• Williams RM et al.,

Profiling of immune-related gene expression in children with familial hypercholesterolaemia

• Narverud I et al.,

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

• House IG et al.,

Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis

• Cao Y et al.,

CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy

• Xiong Z et al.,

Cytosolic 10-formyltetrahydrofolate dehydrogenase regulates glycine metabolism in mouse liver

• Krupenko NI et al.,

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31

• Chumsri S et al.,

Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesis

• Nfonsam VN et al.,

Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes

• Casanova N et al.,

Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses

• Botton T et al.,

Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey

• Balci S et al.,